The acquisition adds to the rush of dealmaking in the pharmaceuticals sector as cash-rich drugmakers hunt for new sources of growth and innovation Source
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,